WELCOME TO OHPR

The mission of the Office of Health Promotion Research is to further knowledge and understanding of health promotion and disease prevention through the development of theory-based rigorously controlled research in health education and health promotion.

Our current research is primarily focused on the promotion and surveillance of effective breast cancer screening through the Vermont Breast Cancer Surveillance System. We are one of six core sites of the national Breast Cancer Surveillance Consortium, as well as the PROSPR Research Center funded by the National Cancer Institute to conduct research to improve the cancer screening process.

Our earlier research focused on tobacco control through smoking prevention and smoking cessation, AIDS prevention, diabetes prevention, and reducing alcohol use by youth. These research projects grew out of earlier ones which we have carried out since the early 1980s by emeriti faculty members Roger H. Secker-Walker M.D., John K. Worden, Ph.D., Brian S. Flynn, Sc.D., Berta Geller, Ed.D., and Laura J. Solomon, Ph.D.

 


UVM COM PostDoc award Hart
Digital Mammography
Larner COM and UVM aerial view
  • Reopening Schools Safely: A Q & A with Two Pediatric Infectious Disease Experts
    April 13, 2021 by Erin Post
    In the summer of 2020, a commentary in Pediatrics by William Raszka, M.D., and Ben Lee, M.D., led to a flurry of interest around the globe. The duo of pediatric infectious disease experts found that “children are not significant drivers of the COVID-19 pandemic” based on an analysis of early studies from Switzerland, China, France and Australia. They wrote: “On the basis of these data, SARS-CoV-2 transmission in schools may be less important in community transmission than initially feared.”
  • Holcombe Named UVM Cancer Center Director & Hematology/Oncology Division Chief
    April 12, 2021 by Ed Neuert
    Randall F. Holcombe, M.D., M.B.A., has been appointed director of the UVM Cancer Center (UVMCC) and chief of the Division of Hematology and Oncology in the Department of Medicine. Holcombe will officially begin his tenure August 1, 2021.
  • TGIR Research Slam Highlights Progress One Year into Pandemic
    April 7, 2021 by Jennifer Nachbur
    On March 18, 2021, researchers from across UVM came together via Zoom for the second edition of the Translational Global Infectious Diseases Research Center's COVID-19 research slam, titled “UVM Tackles COVID-19: Research Progress and Perspectives One Year into the Pandemic.”